Endovascular therapy for aneurysmal vasospasm.

Crit Care Clin

Department of Neurological Surgery, University of Washington, Seattle, USA.

Published: October 1999

Endovascular treatment of cerebral vasospasm induced by subarachnoid hemorrhage has become a useful therapy. The two main treatments that have been used are balloon angioplasty and intra-arterial papaverine infusion. Both treatments have been shown to reverse subarachnoid hemorrhage-induced vascular spasm, increase cerebral blood flow and improve delayed ischemic neurologic deficits induced by vasospasm. Balloon angioplasty is superior to papaverine for treatment of proximal vessel vasospasm by virtue of a more sustained effect on the vessels. Papaverine can be useful as an adjunct to balloon angioplasty and also for the treatment of distal vessels that are not accessible for balloon angioplasty.

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0749-0704(05)70082-8DOI Listing

Publication Analysis

Top Keywords

balloon angioplasty
16
endovascular therapy
4
therapy aneurysmal
4
vasospasm
4
aneurysmal vasospasm
4
vasospasm endovascular
4
endovascular treatment
4
treatment cerebral
4
cerebral vasospasm
4
vasospasm induced
4

Similar Publications

Background: Drug-coated balloons (DCB) can decrease the incidence of restenosis in the treatment of intracranial atherosclerotic stenosis (ICAS). This study aimed to assess the safety and efficacy of submaximal angioplasty with DCB dilation compared with aggressive angioplasty in patients with symptomatic ICAS.

Methods: This study prospectively and consecutively enrolled patients with symptomatic ICAS who underwent DCB angioplasty between January 2021 and December 2023.

View Article and Find Full Text PDF

Biodegradable Stents in the Treatment of Arterial Stenosis.

J Clin Med

January 2025

Department of Accident and Emergency, Etlik City Hospital, Ankara 06170, Turkey.

Arterial diseases (ADs) are a significant health problem, with high mortality and morbidity rates. Endovascular interventions, such as balloon angioplasty (BA), bare-metal stents (BMSs), drug-eluting stents (DESs) and drug-coated balloons (DCBs), have made significant progress in their treatments. However, the issue has not been fully resolved, with restenosis remaining a major concern.

View Article and Find Full Text PDF

Real-World 12-Month Outcomes with Sirolimus-Coated Balloon Angioplasty for Complex Femoropopliteal Disease.

J Clin Med

January 2025

Department of Vascular and Endovascular Surgery, Rhein Main Vascular Center, Asklepios Clinics Langen, Paulinen Wiesbaden, 63225 Langen, Germany.

: Sirolimus-coated balloons (SCBs) have emerged as a promising alternative to paclitaxel-coated devices for the treatment of femoropopliteal lesions. However, real-world data on SCB performance in also complex peripheral arterial disease remains unknown. We sought to evaluate the safety and 12-month clinical outcomes of the Selution SLR™ balloon angioplasty in a challenging real-world patient cohort.

View Article and Find Full Text PDF

Objective: The gold standard imaging modality for assessing crural arterial disease is digital subtraction angiography (DSA). Using DSA, the operator can estimate the diameter and degree of stenosis and determine the diameter of the balloon. Since these measures are estimates, it allows for interobserver and intraobserver variability.

View Article and Find Full Text PDF

A 52-year-old man with a short chronic total occlusion in the left superficial femoral artery underwent drug-coated balloon (DCB) angioplasty. Evaluation using integrated backscatter intravascular ultrasound revealed that the plaque volume of fibrosis was compressed just after treatment (from 494.67 mm to 398.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!